Richard Danger has a diverse work experience in the field of biotechnology and medical research. Richard is currently serving as the Co-Founder & Chief Technology Advisor at BioMAdvanced Diagnostics, a biotech/medtech start-up aiming to offer companion molecular diagnostic tests and biomarkers related to the immune response of patients. Previously, Richard worked as an Associate Researcher at INSERM U1064 - ITUN from 2015 onwards. Richard also served as an Actionnaire at Time for the Planet starting from 2022. Richard's earlier roles include being a Postdoctoral Research Associate at King's College London from 2012 to 2015 and holding positions as a Postdoctoral Fellow and Engineer/PhD student at INSERM U643 where they focused on microRNA profiling in blood from renal transplanted patients. Richard started their career as an Engineer at Microarray platform - Nantes in 2005.
Richard Danger earned their Master's degree in Immunotechnology from Aix-Marseille University in 2005. Richard then pursued a PhD in Transplantation Immunology at Nantes University from 2008 to 2011. In 2019, they attended Sorbonne Université where they completed a DU.GBM degree in Génie biologique et médical with a focus on Valorisation de la recherche publique ou privée et de l’innovation biomédicale.
Links
This person is not in the org chart
This person is not in any teams
This person is not in any offices